All Stories

  1. A Bayesian approach in design and analysis of pediatric cancer clinical trials
  2. FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome
  3. FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma
  4. Clinical Trial Designs to Evaluate Predictive Biomarkers: What’s Being Estimated?
  5. Meta-analysis of the technical performance of an imaging procedure: Guidelines and statistical methodology
  6. Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871)
  7. Correction: A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation
  8. A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation
  9. An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735
  10. Stereospecific reduction of a potent kinesin spindle protein (KSP) inhibitor in human tissues
  11. Abstract 628: A novel SND1-BRAF fusion confers resistance to the cMet inhibitor PF-04217903 in GTL16 cells
  12. Statistical method on nonrandom clustering with application to somatic mutations in cancer
  13. Association Between Menopausal Transition Stages and Developing Urinary Incontinence
  14. Modeling oncology gene pathways network with multiple genotypes and phenotypes via a copula method
  15. Characterization of Human Corneal Epithelial Cell Model As a Surrogate for Corneal Permeability Assessment: Metabolism and Transport
  16. Factors Associated With Worsening and Improving Urinary Incontinence Across the Menopausal Transition
  17. On the analysis of glycomics mass spectrometry data via the regularized area under the ROC curve